Therapeutic Potential of Spleen Tyrosine Kinase Inhibition for Treating High-Risk Precursor B Cell Acute Lymphoblastic Leukemia Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • Pre-BCR–independent activation of spleen tyrosine kinase plays a pathogenic role in high-risk B cell acute lymphoblastic leukemia.

authors

  • Perova, Tatiana
  • Grandal, Ildiko
  • Nutter, Lauryl MJ
  • Papp, Eniko
  • Matei, Irina R
  • Beyene, Joseph
  • Kowalski, Paul E
  • Hitzler, Johann K
  • Minden, Mark D
  • Guidos, Cynthia J
  • Danska, Jayne S

publication date

  • May 14, 2014

has subject area